Mr William Lee Gaston, LCSW | |
1401 20th St S, Birmingham, AL 35205-4913 | |
(205) 510-2761 | |
(205) 510-2790 |
Full Name | Mr William Lee Gaston |
---|---|
Gender | Male |
Speciality | Clinical Social Worker |
Experience | 29 Years |
Location | 1401 20th St S, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174576318 | NPI | - | NPPES |
51516719 | Other | AL | BLUE CROSS BLUE SHIELD |
6264827 | Other | AL | ALL KIDS INS. (UBH) |
51521558 | Other | AL | BLUE CROSS BLUE SHIELD |
9101407 | Other | AL | AETNA |
6264827 | Other | AL | UNITED BEHAVIORAL HEALTH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 1361C (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pitts Mental Health Associates Inc | 6103853445 | 9 |
News Archive
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier management solutions, today announced that the University of Bath will deploy SciQuest as part of a new eMarketplace.
A leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
› Verified 7 days ago
Entity Name | Pitts Mental Health Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851301931 PECOS PAC ID: 6103853445 Enrollment ID: O20050719000694 |
News Archive
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier management solutions, today announced that the University of Bath will deploy SciQuest as part of a new eMarketplace.
A leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mr William Lee Gaston, LCSW 1401 20th St S, Birmingham, AL 35205-4913 Ph: (205) 510-2761 | Mr William Lee Gaston, LCSW 1401 20th St S, Birmingham, AL 35205-4913 Ph: (205) 510-2761 |
News Archive
The age-related increase in the risk of severe disease and death from COVID-19 mirrors earlier patterns seen with infections. Such trends may help understand the mechanisms underlying the clinical feature. A recent study published in the preprint server medRxiv* in August 2020 shows the effect of age and sex on COVID-19 hospitalization rates in the USA and helps understand how immune function is involved in this pandemic.
SciQuest, Inc., a leading provider of on-demand strategic procurement and supplier management solutions, today announced that the University of Bath will deploy SciQuest as part of a new eMarketplace.
A leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
› Verified 7 days ago
Tara L Foley, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3600 7th Ct S Ste 100, Birmingham, AL 35222 Phone: 205-945-7483 Fax: 205-945-7083 | |
Page Rubin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Century Park S Bldg 300, Birmingham, AL 35226 Phone: 205-942-3200 | |
Christa Devaughn Brown, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3220 5th Ave S Ste 100, Birmingham, AL 35222 Phone: 205-877-8677 Fax: 205-877-8675 | |
Amy Daniel Pribyl, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Muriel C. Thompson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1037 22nd Street South, Suite 200, Birmingham, AL 35205 Phone: 205-326-1513 Fax: 205-326-1514 | |
Mrs. Dorinda A Smith, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 129 E Park Cir, Birmingham, AL 35235 Phone: 205-836-7283 Fax: 205-836-9594 | |
Melissa Evans, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 19th St S, Birmingham, AL 35233 Phone: 205-369-0865 |